Latest Conferences

SORT-OUT and BIONYX Successfully Demonstrate Non-Inferiority in the World of Drug-Eluting Stents

Findings from the SORT-OUT trial, presented at the 30th annual Transcatheter Cardiovascular…

Biodegradable Polymer Sirolimus- Eluting Stent Proven Non-Inferior to Durable-Polymer, Everolimus-Eluting Stent

Results of the BIOSCIENCE study that were presented at the ESC Annual…

Treating the culprit lesion associated with decreased mortality versus immediate multi-vessel PCI in cardiogenic shock

 In a randomized multi-center clinical trial that enrolled more than 700 patients…

Coronary Microvascular Dysfunction: A Promising Therapeutic Target in Heart Failure with Preserved EF?

PROMIS-HFpEF (PRevalence Of MIcrovascular dySfunction in Heart Failure with Preserved Ejection Fraction)…

ESC at a Glance: The Trials Were Largely Negative, The Science Was Positive

The Canadian SCAD Study The Canadian SCAD study investigated the risk factors…

Lorcaserin proven safe as weight loss agent in obese patients

The selective serotonin 2c receptor agonist, Lorcaserin has been proven to be…

Transcatheter Interatrial shunt device appears safe at 1 year for heart failure with preserved ejection fraction

The 1-year results of a phase 2, sham-controlled RCT have confirmed the…

Omega-3 fatty acid Supplements Show No Benefit in Cardiovascular Prevention in Diabetes

A randomized trial in patients with diabetes without evidence of cardiovascular disease…

Aspirin Vs Placebo In Cardiovascular Event Reduction In Diabetes

A randomized 15,480 patient strong UK based trial comparing Aspirin (ASA) versus…

Antithrombotic therapy post TAVR: A double edged sword?

A multicenter, prospective nation-wide French registry evaluated whether oral anticoagulation therapy was…

Conservative Management Should be First Line Therapy for SCAD

Spontaneous coronary artery dissection (SCAD) is an underdiagnosed, poorly misunderstood condition. The…

Low Dose Rivaroxaban Plus Aspirin Reduces Major Adverse Limb Events in COMPASS

According to a new subgroup analysis of the COMPASS trial published in…

Clinician Education about Peripheral Arterial Disease

Dr. Andrew Klein and Dr. C. Michael Gibson Discuss

Vascular Access Complications

Dr. Aravinda Nanjundappa and Dr. C. Michael Gibson Discuss

SCAI Global Focus

Dr. Ashok Seth and Dr. Srihari Naidu Discuss